Literature DB >> 30692148

Facilitation of Chemotaxis Activity of Mesenchymal Stem Cells via Stromal Cell-Derived Factor-1 and Its Receptor May Promote Ectopic Ossification of Human Spinal Ligaments.

Shunfu Chin1, Ken-Ichi Furukawa2, Keigo Kurotaki1, Shunpei Nagasaki1, Kanichiro Wada1, Gentaro Kumagai1, Shigeru Motomura1, Yasuyuki Ishibashi1.   

Abstract

Mesenchymal stem cells (MSCs) have been used to elucidate the pathogenesis of numerous diseases. Our recent study showed that MSCs may conduce to the ossification of spinal ligaments. Stromal cell-derived factor-1 (SDF-1) and CXC chemokine receptor 4 (CXCR4) regulate MSC migration. Moreover, their expression is elevated in sites of damage and remodeling in pathologic states. We explored the possible role of the SDF-1/CXCR4 axis in the chemotactic behavior of MSCs in the ossification of spinal ligaments. Specimens of thoracic vertebra ossified ligamentum flavum (OLF) and non-OLF plaques were received from patients in whom we had performed spine surgery. Paraffin-embedded tissue sections were prepared for immunohistochemical staining. Cultured MSCs from the ligamentum flavum were prepared for in vitro analyses. We observed SDF-1 and CXCR4 localization immunohistochemically in the perivascular area and collagenous matrix of ligaments and in chondrocytes near the ossification front of OLF. And then, immunohistochemical staining showed a close relationship between MSCs and the SDF-1/CXCR4 axis. In the in vitro analyses, expression of the SDF-1/CXCR4 and the migratory capacity of MSCs in OLF were remarkably higher compared with non-OLF MSCs. Furthermore, the migration of MSCs was upregulated by SDF-1 and downregulated by treatment with AMD3100 (C28H54N88HCl), a specific antagonist for CXCR4. All in vitro test data showed a significant difference in MSCs from OLF compared with non-OLF MSCs. Our results reveal that the SDF-1/CXCR4 axis may contribute to an MSC-mediated increase in the ossification process, indicating that the SDF-1/CXCR4 axis may become a potential target for a novel therapeutic strategy for ossification of spinal ligaments.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30692148     DOI: 10.1124/jpet.118.254367

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

Review 1.  Treatment and application of stem cells from different sources for cartilage injury: a literature review.

Authors:  Pengzhen Wang; Shaoheng Zhang; Qingqi Meng; Pingping Zhu; Wei Yuan
Journal:  Ann Transl Med       Date:  2022-05

2.  Cyasterone accelerates fracture healing by promoting MSCs migration and osteogenesis.

Authors:  Junlang Zhu; Yamei Liu; Chen Chen; Hongtai Chen; Jiewen Huang; Yiwen Luo; Kewei Zhao; Dongfeng Chen; Zhiming Xu; Wangyang Li; Xunchao Zhang; Yunpu Xiong; Liangliang Xu; Bin Wang
Journal:  J Orthop Translat       Date:  2021-02-19       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.